.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fish and Richardson
Deloitte
Fuji
Novartis
Accenture
Teva
Cantor Fitzgerald
UBS
Cerilliant

Generated: June 28, 2017

DrugPatentWatch Database Preview

DURACLON Drug Profile

« Back to Dashboard

What is the patent landscape for Duraclon, and when can generic versions of Duraclon launch?

Duraclon is a drug marketed by Mylan Institutional and is included in one NDA.

The generic ingredient in DURACLON is clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the clonidine hydrochloride profile page.

Summary for Tradename: DURACLON

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list34
Clinical Trials: see list6
Patent Applications: see list1,299
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DURACLON at DailyMed

Pharmacology for Tradename: DURACLON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
DURACLON
clonidine hydrochloride
INJECTABLE;INJECTION020615-001Oct 2, 1996APRXYesNo► Subscribe► Subscribe
Mylan Institutional
DURACLON
clonidine hydrochloride
INJECTABLE;INJECTION020615-002Apr 27, 1999APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Accenture
Johnson and Johnson
Cipla
Chinese Patent Office
Federal Trade Commission
Argus Health
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot